Peng‐Fei Cui
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Microbiology top 2%
- Antimicrobial Peptides and Activities
Papers in
-
- RNA Interference and Gene Delivery 18
- Advanced biosensing and bioanalysis techniques 15
-
- Nanoplatforms for cancer theranostics 26
- Co-authors
- Hu‐Lin Jiang (32 shared papers)Lei Xing (30 shared papers)Guo‐Xin Jin (19 shared papers)Jianhao Wang (31 shared papers)Cheng Wang (25 shared papers)Jian-Bin Qiao (18 shared papers)Yue‐Jian Lin (8 shared papers)Yu‐Kyoung Oh (3 shared papers)
- Journals
- Journal of Controlled Release (6 papers)Journal of the American Chemical Society (6 papers)International Journal of Pharmaceutics (6 papers)Biomaterials Science (5 papers)Chemical Communications (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Peng‐Fei Cui
116 papers receiving 3.5k citations
Peng‐Fei Cui's Hit Papers
Peers
Comparison fields: 5 of 151
- Biomaterials 705
- Microbiology 227
- Pharmaceutical Science 163
- Biomedical Engineering 1.1k
- Molecular Medicine 120
Countries citing papers authored by Peng‐Fei Cui
This map shows the geographic impact of Peng‐Fei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng‐Fei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng‐Fei Cui more than expected).
Fields of papers citing papers by Peng‐Fei Cui
This network shows the impact of papers produced by Peng‐Fei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng‐Fei Cui. The network helps show where Peng‐Fei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng‐Fei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Applications of π-π stacking interactions in the design of drug-delivery systems Hit paper breakdown → | 2018 | 376 |
| 2 | Antimicrobial peptides towards clinical application: Delivery and formulation Hit paper breakdown → | 2021 | 190 |
| 3 | 2010 | 166 | |
| 4 | 2017 | 138 | |
| 5 | 2019 | 118 | |
| 6 | 2022 | 109 | |
| 7 | 2015 | 98 | |
| 8 | 2020 | 98 | |
| 9 | 2019 | 94 | |
| 10 | 2013 | 94 | |
| 11 | 2019 | 92 | |
| 12 | 2018 | 88 | |
| 13 | 2018 | 83 | |
| 14 | 2017 | 82 | |
| 15 | 2021 | 80 | |
| 16 | 2016 | 65 | |
| 17 | 2016 | 56 | |
| 18 | 2014 | 55 | |
| 19 | 2019 | 55 | |
| 20 | 2017 | 51 |
About Peng‐Fei Cui
Peng‐Fei Cui is a scholar working on Molecular Biology, Biomedical Engineering, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Biomaterials, having authored 125 papers that have together received 3.5k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (26 papers), Boron Compounds in Chemistry (21 papers), RNA Interference and Gene Delivery (18 papers), Nanoparticle-Based Drug Delivery (15 papers), Advanced biosensing and bioanalysis techniques (15 papers), Radiopharmaceutical Chemistry and Applications (14 papers), Organoboron and organosilicon chemistry (12 papers) and Antimicrobial Peptides and Activities (10 papers). The work is most often cited by research in Biomaterials (705 citations), Microbiology (227 citations), Pharmaceutical Science (163 citations), Biomedical Engineering (1.1k citations) and Molecular Medicine (120 citations). Peng‐Fei Cui has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Hu‐Lin Jiang, Lei Xing, Guo‐Xin Jin, Jianhao Wang, Cheng Wang, Jian-Bin Qiao, Yue‐Jian Lin, Yu‐Kyoung Oh, Yujing He and Jiang Xia. Their work appears in journals such as Journal of Controlled Release, Journal of the American Chemical Society, International Journal of Pharmaceutics, Biomaterials Science and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.